1. Home
  2. LFVN vs VRCA Comparison

LFVN vs VRCA Comparison

Compare LFVN & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

N/A

Current Price

$4.80

Market Cap

78.0M

Sector

Health Care

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

N/A

Current Price

$3.80

Market Cap

88.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFVN
VRCA
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
88.0M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
LFVN
VRCA
Price
$4.80
$3.80
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$7.00
★ $13.83
AVG Volume (30 Days)
23.9K
★ 54.5K
Earning Date
11-09-2026
11-12-2026
Dividend Yield
★ 4.24%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $203,204,000.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.99
$60.79
P/E Ratio
★ N/A
N/A
Revenue Growth
1.86
★ 370.22
52 Week Low
$3.90
$3.08
52 Week High
$11.71
$9.82

Technical Indicators

Market Signals
Indicator
LFVN
VRCA
Relative Strength Index (RSI) 36.51 53.62
Support Level $4.10 $3.30
Resistance Level $5.37 $4.17
Average True Range (ATR) 0.33 0.28
MACD -0.10 0.08
Stochastic Oscillator 29.14 89.94

Price Performance

Historical Comparison
LFVN
VRCA

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: